Dublin, Ireland, 19-20 October 2017
The presentations in this page have been archived and are no longer available.
| Topic | Speaker |
|---|---|
| Microbiology | |
| Validation of alternative microbiological methods for food, feed and environmental samples | Hilde S. Norli |
| EQA and Chlamydia; protecting the community from the spread of STIs | Rosanna Peeling |
| Pre and post examination of microbiology by EQA | Michael Noble |
| Adam Uldall Lecture | |
| The role of EQA in the verification of in-vitro medical diagnostics | Mauro Panteghini |
| Plenary lecture | |
| EQA for developing countries, the role of WHO | Willy Urassa |
| Statistics in EQA | |
| A critical view on ISO standard 13528 | Wim Coucke |
| Statistical approach for optimization of EQA studies of molecular and serological viral diagnostics | Matthias Niedrig |
| The members' session | |
| Definition of EQAS allowable limits for HbA1c: a candidate method | Anne Vassault |
| Quality Monitoring of pre-analytical sample labelling | Ann Leonard |
| Abstract presentations | |
| Biochemical assays of human seminal plasma: the experience of a French EQA program | Safouane Hamdi |
| Assessment of Laboratory Performance in the Molecular Detection of Influenza A, Influenza B and RSV methods through International EQA Scheme for Multiplex Assays | Niina Kivi |
| IHC Breast Audit | Tony Badrick |